260 related articles for article (PubMed ID: 17982179)
1. A novel tri-functional antibody fusion protein with improved pharmacokinetic properties generated by fusing a bispecific single-chain diabody with an albumin-binding domain from streptococcal protein G.
Stork R; Müller D; Kontermann RE
Protein Eng Des Sel; 2007 Nov; 20(11):569-76. PubMed ID: 17982179
[TBL] [Abstract][Full Text] [Related]
2. The effects of affinity and valency of an albumin-binding domain (ABD) on the half-life of a single-chain diabody-ABD fusion protein.
Hopp J; Hornig N; Zettlitz KA; Schwarz A; Fuss N; Müller D; Kontermann RE
Protein Eng Des Sel; 2010 Nov; 23(11):827-34. PubMed ID: 20817756
[TBL] [Abstract][Full Text] [Related]
3. Improved pharmacokinetics of recombinant bispecific antibody molecules by fusion to human serum albumin.
Müller D; Karle A; Meissburger B; Höfig I; Stork R; Kontermann RE
J Biol Chem; 2007 Apr; 282(17):12650-60. PubMed ID: 17347147
[TBL] [Abstract][Full Text] [Related]
4. Half-life extension of a single-chain diabody by fusion to domain B of staphylococcal protein A.
Unverdorben F; Färber-Schwarz A; Richter F; Hutt M; Kontermann RE
Protein Eng Des Sel; 2012 Feb; 25(2):81-8. PubMed ID: 22238430
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution of a bispecific single-chain diabody and its half-life extended derivatives.
Stork R; Campigna E; Robert B; Müller D; Kontermann RE
J Biol Chem; 2009 Sep; 284(38):25612-9. PubMed ID: 19628871
[TBL] [Abstract][Full Text] [Related]
6. Recombinant bispecific antibodies for the targeting of adenoviruses to CEA-expressing tumour cells: a comparative analysis of bacterially expressed single-chain diabody and tandem scFv.
Korn T; Nettelbeck DM; Völkel T; Müller R; Kontermann RE
J Gene Med; 2004 Jun; 6(6):642-51. PubMed ID: 15170735
[TBL] [Abstract][Full Text] [Related]
7. Diabody-based recombinant formats of humanized IgG-like bispecific antibody with effective retargeting of lymphocytes to tumor cells.
Asano R; Kawaguchi H; Watanabe Y; Nakanishi T; Umetsu M; Hayashi H; Katayose Y; Unno M; Kudo T; Kumagai I
J Immunother; 2008 Oct; 31(8):752-61. PubMed ID: 18779744
[TBL] [Abstract][Full Text] [Related]
8. Albumin-binding domain from Streptococcus zooepidemicus protein Zag as a novel strategy to improve the half-life of therapeutic proteins.
Cantante C; Lourenço S; Morais M; Leandro J; Gano L; Silva N; Leandro P; Serrano M; Henriques AO; Andre A; Cunha-Santos C; Fontes C; Correia JDG; Aires-da-Silva F; Goncalves J
J Biotechnol; 2017 Jul; 253():23-33. PubMed ID: 28549690
[TBL] [Abstract][Full Text] [Related]
9. N-glycosylation as novel strategy to improve pharmacokinetic properties of bispecific single-chain diabodies.
Stork R; Zettlitz KA; Müller D; Rether M; Hanisch FG; Kontermann RE
J Biol Chem; 2008 Mar; 283(12):7804-12. PubMed ID: 18211902
[TBL] [Abstract][Full Text] [Related]
10. Preferential heterodimerization of a bispecific diabody based on a humanized anti-EGFR antibody 528.
Asano R; Sone Y; Ikoma K; Hayashi H; Nakanishi T; Umetsu M; Katayose Y; Unno M; Kudo T; Kumagai I
Protein Eng Des Sel; 2008 Oct; 21(10):597-603. PubMed ID: 18621782
[TBL] [Abstract][Full Text] [Related]
11. Generation of single-chain bispecific green fluorescent protein fusion antibodies for imaging of antibody-induced T cell synapses.
Stamova S; Feldmann A; Cartellieri M; Arndt C; Koristka S; Apel F; Wehner R; Schmitz M; Bornhäuser M; von Bonin M; Ehninger G; Bartsch H; Bachmann M
Anal Biochem; 2012 Apr; 423(2):261-8. PubMed ID: 22274538
[TBL] [Abstract][Full Text] [Related]
12. Potent control of tumor growth by CEA/CD3-bispecific single-chain antibody constructs that are not competitively inhibited by soluble CEA.
Lutterbuese R; Raum T; Kischel R; Lutterbuese P; Schlereth B; Schaller E; Mangold S; Rau D; Meier P; Kiener PA; Mulgrew K; Oberst MD; Hammond SA; Baeuerle PA; Kufer P
J Immunother; 2009 May; 32(4):341-52. PubMed ID: 19342971
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo properties of a dimeric bispecific single-chain antibody IgG-fusion protein for depletion of CCR2+ target cells in mice.
Schneider MA; Brühl H; Wechselberger A; Cihak J; Stangassinger M; Schlöndorff D; Mack M
Eur J Immunol; 2005 Mar; 35(3):987-95. PubMed ID: 15719369
[TBL] [Abstract][Full Text] [Related]
14. Application of the Fc fusion format to generate tag-free bi-specific diabodies.
Asano R; Ikoma K; Kawaguchi H; Ishiyama Y; Nakanishi T; Umetsu M; Hayashi H; Katayose Y; Unno M; Kudo T; Kumagai I
FEBS J; 2010 Jan; 277(2):477-87. PubMed ID: 20015073
[TBL] [Abstract][Full Text] [Related]
15. Antibody-IL-2 fusion proteins: a novel strategy for immune protection.
Penichet ML; Harvill ET; Morrison SL
Hum Antibodies; 1997; 8(3):106-18. PubMed ID: 9322080
[TBL] [Abstract][Full Text] [Related]
16. T-cell killing of heterogenous tumor or viral targets with bispecific chimeric immune receptors.
Patel SD; Moskalenko M; Tian T; Smith D; McGuinness R; Chen L; Winslow GA; Kashmiri S; Schlom J; Stanners CP; Finer MH; McArthur JG
Cancer Gene Ther; 2000 Aug; 7(8):1127-34. PubMed ID: 10975673
[TBL] [Abstract][Full Text] [Related]
17. Engineered protein scaffolds for molecular recognition.
Skerra A
J Mol Recognit; 2000; 13(4):167-87. PubMed ID: 10931555
[TBL] [Abstract][Full Text] [Related]
18. Immunogencity of HSA-L7/L12 (Brucella abortus ribosomal protein) in an animal model.
Pakzad I; Rezaee A; Rasaee MJ; Tabbaraee B; Delpisheh A
Iran J Immunol; 2009 Mar; 6(1):12-21. PubMed ID: 19293473
[TBL] [Abstract][Full Text] [Related]
19. A Fab-Selective Immunoglobulin-Binding Domain from Streptococcal Protein G with Improved Half-Life Extension Properties.
Unverdorben F; Hutt M; Seifert O; Kontermann RE
PLoS One; 2015; 10(10):e0139838. PubMed ID: 26430884
[TBL] [Abstract][Full Text] [Related]
20. A novel CD19-directed recombinant bispecific antibody derivative with enhanced immune effector functions for human leukemic cells.
Kellner C; Bruenke J; Stieglmaier J; Schwemmlein M; Schwenkert M; Singer H; Mentz K; Peipp M; Lang P; Oduncu F; Stockmeyer B; Fey GH
J Immunother; 2008; 31(9):871-84. PubMed ID: 18833000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]